Piper Sandler 37th Annual Healthcare Conference December 2, 2025 11:00 AM ESTCompany ParticipantsJames Mock - Chief ...

Piper Sandler 37th Annual Healthcare Conference December 2, 2025 8:30 AM ESTCompany ParticipantsJacqueline Shea - ...

RNA vaccine technology has emerged as a groundbreaking approach in the field of immunology and infectious disease prevention.

“MAHA’s growth is a sign of its success,” said HHS spokesperson Andrew Nixon. “Secretary Kennedy is leading a broad coalition to make Americans healthier, guided by transparency, accountability and ...

mRNA, widely known from the COVID-19 vaccine, is not actually a "therapeutic agent," but a technology that delivers the ...

Ongoing federal support for mRNA technology and research could make good on a longstanding presidential promise to cure cancer, according to Jeff Coller, Bloomberg Distinguished Professor of RNA ...

In two experiments, researchers have found that introducing people to "mental models" about how mRNA vaccination works and ...

Researchers at the Icahn School of Medicine at Mount Sinai and collaborators have reported early success with a novel ...

In a Phase 3 trial of more than 18,000 volunteers across three countries, an mRNA influenza vaccine from Pfizer has outperformed standard seasonal flu shots by 34.5%. It's yet another sign that this ...

Pfizer's mRNA flu vaccine worked better than a standard flu shot in a large Phase 3 trial, researchers reported. The results, published Nov. 19 in The New England Journal of Medicine, suggest that ...

Correcting misinformation after it has gone viral is a common way of informing the public that what they've encountered may ...

(Reuters) -Moderna said on Wednesday it would now operate full end-to-end manufacturing for its mRNA medicines in the U.S., marking a major step in strengthening the company's domestic production ...